Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed on September 15, 2025, and announced on September 16, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Shares Purchased | 1,500,000 |
| Transaction Date | September 15, 2025 |
| Highest Price Paid | 360.60 pence |
| Lowest Price Paid | 355.70 pence |
| Volume Weighted Average Price | 357.72 pence |
| Exchanges | LSE, CBOE (UK)/BXE, CBOE (UK)/CXE |
Material Changes
Following this transaction, which represents the second tranche of a buyback programme announced on July 31, 2025, the company's registered share capital remains 8,952,353,648 ordinary shares. The number of shares held as treasury shares increased to 4,001,961. Consequently, the number of ordinary shares with voting rights is now 8,948,351,687.
Outlook and Management Commentary
Management intends to hold the purchased shares as treasury shares. The filing includes standard disclaimers stating the announcement does not constitute an offer or solicitation of securities. No specific guidance, risk factors, or unusual items beyond the routine share buyback were disclosed in this specific report.
Investor Verification Checklist
- Verify the total number of treasury shares held (4,001,961) against the company's latest capital structure.
- Confirm the remaining authorization under the share buyback programme announced on July 31, 2025.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular execution details.
- Check the updated voting share count (8,948,351,687) for compliance with FCA Disclosure Guidance and Transparency Rules.